NasdaqGM - Delayed Quote USD

Biora Therapeutics, Inc. (BIOR)

Compare
2.3800 -0.1100 (-4.42%)
At close: 4:00 PM EST
2.4500 +0.07 (+2.94%)
After hours: 4:26 PM EST
Advanced Chart
Loading Chart for BIOR
DELL
  • Previous Close 2.4900
  • Open 2.5300
  • Bid 2.3000 x 100
  • Ask 2.5000 x 100
  • Day's Range 2.3000 - 2.5300
  • 52 Week Range 2.3000 - 19.9000
  • Volume 86,751
  • Avg. Volume 52,607
  • Market Cap (intraday) 10.527M
  • Beta (5Y Monthly) 1.28
  • PE Ratio (TTM) --
  • EPS (TTM) -49.3000
  • Earnings Date Nov 14, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 97.50

Biora Therapeutics, Inc., a clinical-stage biotechnology company, engages in developing oral biotherapeutics in the United States. The company offers NaviCap, a targeted oral delivery platform for delivery of therapeutics in the gastrointestinal tract to enhance the treatment of inflammatory bowel diseases; and BioJet, a systemic oral delivery platform designs to replace injection with needle-free, oral delivery of large molecules for management of chronic diseases. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.

www.bioratherapeutics.com

58

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

More about Biora Therapeutics, Inc.

Recent News: BIOR

View More
View More

Performance Overview: BIOR

Trailing total returns as of 11/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

BIOR
82.37%
S&P 500
24.72%

1-Year Return

BIOR
82.63%
S&P 500
34.85%

3-Year Return

BIOR
99.68%
S&P 500
27.04%

5-Year Return

BIOR
99.94%
S&P 500
92.05%

Compare To: BIOR

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

BIOR
Biora Therapeutics, Inc.
2.3800
-4.42%
Mkt Cap 10.527M
Industry Biotechnology
EYEN
Eyenovia, Inc.
0.3401
-16.54%
Mkt Cap 29.114M
Industry Biotechnology
REVB
Revelation Biosciences, Inc.
0.8366
-8.07%
Mkt Cap 3.144M
Industry Biotechnology
LCTX
Lineage Cell Therapeutics, Inc.
0.8850
-3.07%
Mkt Cap 167.121M
Industry Biotechnology
LGVN
Longeveron Inc.
2.0800
-1.89%
Mkt Cap 29.868M
Industry Biotechnology
ENSC
Ensysce Biosciences, Inc.
0.6357
-10.34%
Mkt Cap 9.481M
Industry Biotechnology
RVPH
Reviva Pharmaceuticals Holdings, Inc.
1.2100
-3.20%
Mkt Cap 40.464M
Industry Biotechnology
APVO
Aptevo Therapeutics Inc.
0.2410
-0.74%
Mkt Cap 4.461M
Industry Biotechnology
ADTX
Aditxt, Inc.
0.3485
+0.17%
Mkt Cap 3.046M
Industry Biotechnology
CYCC
Cyclacel Pharmaceuticals, Inc.
0.3933
-12.60%
Mkt Cap 846,039
Industry Biotechnology
DARE
Daré Bioscience, Inc.
3.5650
-7.04%
Mkt Cap 30.468M
Industry Biotechnology

Statistics: BIOR

View More

Valuation Measures

Annual
As of 11/13/2024

  • Market Cap

    11.01M

  • Enterprise Value

    52.65M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    12.90

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    61.22

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -125.06%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    860k

  • Net Income Avi to Common (ttm)

    -86.81M

  • Diluted EPS (ttm)

    -49.3000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.33M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -19.18M

View More

Research Analysis: BIOR

View More

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 318k
Earnings -2.63M
Q1'24
Q2'24
-4M
-3M
-2M
-1M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

45.00
97.50 Average
2.3800 Current
150.00 High
 
View More

Company Insights: BIOR

People Also Watch

COSM Cosmos Health Inc.
0.6533
-5.84%
 
PALI Palisade Bio, Inc.
2.6200
+19.09%
 
KPRX Kiora Pharmaceuticals, Inc.
3.3969
-1.25%
 
DRMA Dermata Therapeutics, Inc.
1.1890
-5.63%
 
PXMD PaxMedica, Inc.
0.1100
0.00%
 
JSPR Jasper Therapeutics, Inc.
22.10
-3.07%
 
CDIO Cardio Diagnostics Holdings, Inc.
0.2652
-13.84%
 
GNS Genius Group Limited
0.8734
-7.97%
 
PBLA Panbela Therapeutics, Inc.
0.3010
-5.35%
 
QNRX Quoin Pharmaceuticals, Ltd.
0.6070
-1.48%
 
ENSC Ensysce Biosciences, Inc.
0.6357
-10.34%
 
HSCS HeartSciences Inc.
2.6300
-5.05%
 
TCBP TC Biopharm (Holdings) Plc
0.6488
-30.24%
 
RNAZ TransCode Therapeutics, Inc.
0.3499
-3.95%
 
MEGL Magic Empire Global Limited
0.5083
+1.25%
 
VRAX Virax Biolabs Group Limited
1.9000
-2.06%